Oak Street Health, Inc. (NYSE:OSH) – Investment analysts at Cantor Fitzgerald issued their FY2021 EPS estimates for shares of Oak Street Health in a research note issued on Tuesday, April 20th. Cantor Fitzgerald analyst S. Halper expects that the company will post earnings of ($1.04) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating and a $75.00 target price on the stock.

Other equities analysts also recently issued reports about the stock. Evercore ISI assumed coverage on shares of Oak Street Health in a research note on Monday, March 22nd. They issued an “outperform” rating and a $75.00 price target on the stock. Canaccord Genuity initiated coverage on shares of Oak Street Health in a research report on Tuesday, March 2nd. They set a “buy” rating and a $67.00 price target for the company. Morgan Stanley lifted their price target on shares of Oak Street Health from $73.00 to $79.00 and gave the company an “overweight” rating in a research report on Thursday, March 18th. Piper Sandler lifted their price target on shares of Oak Street Health from $59.00 to $69.00 in a research report on Wednesday, February 17th. Finally, Wolfe Research started coverage on shares of Oak Street Health in a report on Thursday, January 28th. They issued an “outperform” rating and a $62.00 price objective for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and thirteen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average price target of $67.54.

Shares of NYSE OSH opened at $59.73 on Thursday. The company’s 50-day simple moving average is $56.76 and its 200-day simple moving average is $54.89. Oak Street Health has a 52-week low of $37.11 and a 52-week high of $66.31.

Oak Street Health (NYSE:OSH) last issued its earnings results on Monday, March 8th. The company reported ($0.40) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.25) by ($0.15). The business had revenue of $248.70 million for the quarter, compared to analyst estimates of $231.79 million. The business’s quarterly revenue was up 43.3% compared to the same quarter last year.

In other news, insider Brian Clem sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, April 15th. The shares were sold at an average price of $57.50, for a total transaction of $575,000.00. Following the completion of the sale, the insider now owns 621,619 shares in the company, valued at approximately $35,743,092.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Robert Guenthner sold 5,902 shares of the company’s stock in a transaction on Thursday, February 25th. The shares were sold at an average price of $55.82, for a total transaction of $329,449.64. Following the completion of the sale, the insider now owns 560,524 shares of the company’s stock, valued at approximately $31,288,449.68. The disclosure for this sale can be found here. Insiders have sold a total of 7,546,937 shares of company stock valued at $409,378,531 in the last 90 days. Insiders own 5.66% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in the stock. HM Payson & Co. purchased a new stake in Oak Street Health in the 3rd quarter valued at $29,000. FIL Ltd raised its position in Oak Street Health by 0.6% in the 4th quarter. FIL Ltd now owns 153,551 shares of the company’s stock valued at $9,391,000 after purchasing an additional 883 shares during the last quarter. Sowell Financial Services LLC raised its position in Oak Street Health by 69.9% in the 4th quarter. Sowell Financial Services LLC now owns 2,443 shares of the company’s stock valued at $149,000 after purchasing an additional 1,005 shares during the last quarter. Sei Investments Co. raised its position in Oak Street Health by 9.8% in the 4th quarter. Sei Investments Co. now owns 16,963 shares of the company’s stock valued at $1,037,000 after purchasing an additional 1,514 shares during the last quarter. Finally, Arkadios Wealth Advisors purchased a new stake in Oak Street Health in the 4th quarter valued at $121,000. Hedge funds and other institutional investors own 66.59% of the company’s stock.

Oak Street Health Company Profile

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2020, it operated 79 centers in Illinois, Indiana, Michigan, Mississippi, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, and Texas.

See Also: Accumulation/Distribution

Earnings History and Estimates for Oak Street Health (NYSE:OSH)

Receive News & Ratings for Oak Street Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oak Street Health and related companies with MarketBeat.com's FREE daily email newsletter.